𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B

✍ Scribed by Themistoklis Vassiliadis; Konstantinos Tziomalos; Kalliopi Patsiaoura; Thomas Zagris; Olga Giouleme; Konstantinos Soufleris; Nikolaos Grammatikos; Konstantinos Theodoropoulos; Alexandros Mpoumponaris; Konstantina Dona; Petros Zezos; Nikolaos Nikolaidis; Eleni Orfanou-Koumerkeridou; Aikaterini Balaska; Nikolaos Eugenidis

Book ID
108951550
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
88 KB
Volume
22
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A viral kinetic study using pegylated in
A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative
✍ Vassiliki-Anastasia Sypsa; Konstantinos Mimidis; Nicholas C. Tassopoulos; Dimitr πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 428 KB πŸ‘ 2 views

We studied viral dynamic parameters in 44 chronic hepatitis B/hepatitis B e antigen (HBeAg)(؊) patients treated with pegylated interferon alfa-2b (PEG-IFN) 100 or 200 g weekly or lamivudine 100 mg daily or the combination of PEG-IFN 100 or 200 g with lamivudine. Patients receiving PEG-IFN monotherap

Efficacy of adefovir add-on lamivudine r
Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B
✍ Han Jak Ryu; Jung Min Lee; Sang Hoon Ahn; Do Young Kim; Myoung Ha Lee; Kwang-Hyu πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 134 KB πŸ‘ 1 views

## Abstract No study has reported on the comparative effect of adefovir (ADV) add‐on lamivudine (LAM) versus switching to entecavir (ETV) in LAM‐resistant patients with chronic hepatitis B. From October 2007 to September 2008, 92 consecutive LAM‐resistant patients were enrolled (47 LAM + ADV and 45